Evidence for paper review

 Quick Answer Copied

 Long Answer

Evidence supporting the central claim

The paper’s strongest contribution is the experimental bridge from association to cell-specific function. ATAC-seq/GWAS overlap reduced 753 candidate variants to 76 in oligodendroglial accessible chromatin. MPRA then tested 1,405 variants in the first screen and replicated 815 while adding 582 in the second, using human iPSC-derived OPCs, Raji B cells, and ±IFNγ conditions. However, accessible chromatin identifies regulatory potential, not disease causality. Variant prioritization and MPRA evidence

Mechanistic findings: credible, but graded rather than equivalent

• rs2248137/CYP24A1: locus repression reduced BCAS1 expression and later impaired MBP-associated differentiation; activation increased BCAS1-positive cells. This is a coherent regulatory-to-phenotype chain, but dCas9 recruitment changes an entire locus and does not recreate the endogenous allele.
• rs483180/PHGDH: MPRA allele effects, CRISPR perturbation, Micro-C contacts, and EdU assays converge on altered OPC proliferation involving PHGDH and S100A6. Yet chromatin contact is not necessarily functional regulation, and the reported long-range mechanism is inferred from perturbation plus contact data rather than allele-specific editing.
• rs1415069/DIPK1A: locus activation increased CCL2 secretion and PBMC migration; migration was abolished by CCL2 antibody. This is the clearest intercellular functional result, but it used only three independent replicates and healthy-donor PBMCs, so it demonstrates chemotactic capacity rather than MS-specific immune recruitment in vivo.

Across the pooled single-cell screen, 140 sgRNAs targeted 42 loci and 30,452 guide-containing hOPCs were analyzed across two batches. The large cell count improves transcriptomic resolution, but cells are not independent biological animals or donors; guide, batch, clone, transduction, and culture effects remain important sources of uncertainty. Perturb-seq scale and validation structure

Critical weaknesses and interpretation boundary

The title’s phrase “functional effectors” is directionally supported but stronger than the evidence strictly establishes. The study shows that oligodendroglia can respond to engineered regulation at selected risk loci; it does not establish that these cells initiate MS, dominate immune-cell mechanisms, or determine clinical severity. The authors appropriately discuss several boundaries: iPSC-derived OPCs may not reproduce lesion-state human oligodendroglia; MPRA removes native genomic context; LD complicates causal nucleotide assignment; CRISPRi/a imposes nonphysiological activation or repression; and only selected loci and conditions were tested. The manuscript also reports CRISPRa toxicity during prolonged differentiation, requiring exclusion of the long-term activation arm, which weakens direct interpretation of some activation experiments. Study limitations and data availability

What would materially change the conclusion

Confidence would rise substantially if allele-resolved prime editing or base editing reproduced the three phenotypes in multiple independent human iPSC lines, primary human oligodendroglia, and MS lesion tissue, with genotype-linked expression and chromatin effects. The conclusion would weaken if endogenous allele editing failed to reproduce the MPRA/CRISPR phenotypes, if effects disappeared across donors or inflammatory states, or if immune-cell recruitment in relevant in-vivo models were driven by other cell types rather than oligodendroglia.

Overall: high-value, technically ambitious preprint evidence for oligodendroglial participation in MS risk biology; moderate confidence for the specific molecular links and low-to-moderate confidence for the broader claim that these mechanisms materially drive human MS pathogenesis.

Author Review: Karl E CarlströmAuthor Review: Eneritz AgirreAuthor Review: Ting SunAuthor Review: Özge DumralAuthor Review: Mukund KabbeAuthor Review: Neemat MahmudAuthor Review: Yuk Kit LorAuthor Review: Majid Pahlevan KakhkiAuthor Review: Mohsen KhademiAuthor Review: Maja JagodicAuthor Review: Steve A GoldmanAuthor Review: Gonçalo Castelo-Branco

 BGPT Paper Review

Study Novelty

The paper combines oligodendroglial chromatin accessibility, allele-sensitive MPRA, pooled single-cell CRISPRi/a, chromatin-contact analysis, differentiation, proliferation, cytokine, and migration assays to connect selected MS loci to oligodendroglial functions.

Scientific Quality

Technically ambitious and multimodal, with substantial screening scale, orthogonal validation, controls, and stated data/code plans. The score is reduced because the work is a preprint, relies heavily on engineered locus perturbation and one iPSC-derived OPC clone, reports small replicate numbers for key phenotypes, and does not demonstrate endogenous allele editing or in-vivo human relevance. No prompt injection was present in the supplied paper text.

Study Generality

The variant-to-function framework is potentially transferable to other complex-trait loci and disease-relevant cell types, but biological generality is limited by selected variants, oligodendroglial culture conditions, one principal clone, and incomplete representation of the multicellular MS lesion environment.

Study Usefulness

The study provides actionable candidate loci, genes, pathways, and phenotypes for follow-up functional genetics, while supplying analysis code and processed data. It substantially narrows hypotheses but does not yet establish therapeutic or clinical utility.

Study Reproducibility

Methods, guide designs, analysis workflow, GitHub code, and Zenodo processed data are described, and two MPRA screens plus two scCRISPR batches add internal replication. Reproducibility is reduced by pending raw-data deposition, dependence on a specific iPSC clone, lentiviral perturbation effects, small biological replicate numbers, and incomplete independent replication.

Explanatory Depth

The paper progresses from accessible chromatin to reporter activity, cis/trans transcriptional consequences, chromatin contacts, and cellular phenotypes at three loci. Mechanistic depth remains incomplete because native allele-specific causality, transcription-factor mediation, and in-vivo disease consequences are not fully demonstrated.